China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It's establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.
For the moment, the cooperation exists mostly with Europe and the U. S. But Asia's other biotech leaders, Japan, Singapore and Korea, also are recognizing China's potential as an attractive low-cost base to conduct research. These partnerships--and China's advancement in the field of biotechnology--could help benefit the rest of Asia: China's rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.
There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven't met one scientist who believes they are being fully adhered to," says a European science analyst.
If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China.
The mouse on display is most significant in that ______.
A.it has an ear in the shape of a human ear
B.it is unusually small and ugly as a star
C.it is the focus of. the media at the exhibition
D.it indicates China's progress in biotechnology
第1题
主动脉骑跨见于哪种疾病
A、房间隔缺损
B、三尖瓣下移畸形
C、法洛四联症
D、法洛三联症
E、冠心病
第2题
主动脉骑跨见于哪个疾病
A.房间隔缺损
B.三尖瓣下移畸形
C.法洛四联症
D.法洛三联症
E.冠心病
第3题
法洛四联症,对病理生理影响最大的畸形是()。
A.主动脉弓
B.肺动脉狭窄
C.室间隔缺损
D.主动脉骑跨
E.右心室肥厚
第4题
A. 法洛三联症
B. 法洛五联症
C. 巨大室间隔缺损合并艾森门格综合征(EisenmengersyndromE.
D. 右心室双出口
E. 主动脉窦瘤
F . 永存动脉干
第5题
法洛四联症的病理改变中主要畸形的是
A、肺动脉狭窄
B、室间隔缺损
C、主动脉骑跨
D、右心室肥厚
E、主动脉狭窄
第6题
法洛四联症,对病理生理影响最大的畸形是()。
A.主动脉弓
B.肺动脉狭窄
C.室间隔缺损
D.主动脉骑跨
E.右心室肥厚
第7题
不属于法洛四联症四个病理畸形的是
A. 肺动脉狭窄
B. 主动脉骑跨
C. 房间隔缺损
D. 室间隔缺损
E. 右心室肥厚
第8题
法洛四联症,对病理生理影响最大的畸形是()。
A.主动脉弓
B.肺动脉狭窄
C.室间隔缺损
D.主动脉骑跨
E.右心室肥厚
第9题
法洛四联症,对病理生理影响最大的畸形是()。
A.主动脉弓
B.肺动脉狭窄
C.室间隔缺损
D.主动脉骑跨
E.右心室肥厚
为了保护您的账号安全,请在“上学吧”公众号进行验证,点击“官网服务”-“账号验证”后输入验证码“”完成验证,验证成功后方可继续查看答案!